₹1,357.70
-4.40 (-0.32%)
As of 28 Aug 2026, Alivus Life Sciences Ltd share price is ₹1,357.70. The stock opened at ₹1,357.70 and had closed at ₹1,362.10 the previous day. Over the last 52 weeks, the stock has recorded a low of ₹830.00 and a high of ₹1,415.90. In terms of performance, Alivus Life Sciences Ltd share price has increased by 49.62% over the past six months and has increased by 43.75% over the last year.
ALIVUS Charts
Alivus Life Sciences Ltd Overview
Market cap₹16,669 Crs
Volume3,514
Prev. Close₹1,362.10
Year range₹830.00 - ₹1,415.90
Total Value₹47,70,957.80
ISININE03Q201024
About ALIVUS
Alivus Life Sciences is primarily engaged in the development, manufacture, and marketing of active pharmaceutical ingredients.
Alivus Life Sciences Ltd Historical Performance
1 Month Return20.10%
6 Month Return48.69%
3 Year Return119.76%
3 Month Return26.84%
1 Year Return43.00%
5 Year Return100.21%
Alivus Life Sciences Ltd Fundamental Analysis
ROCE(TTM)22.33%
P/E Ratio (TTM)27.64
P/B Ratio5.00
Debt to Equity0.02
ROE16.94%
EPS (TTM)50.64
Dividend Yield0.37%
Book Value271.41
Profit Margin24.00%
Operating Margin29.25%
Alivus Life Sciences Ltd Financials
| Indicator | Jun 26 | Mar 26 | Dec 25 | Sep 25 | Jun 25 |
|---|---|---|---|---|---|
| Revenue | 662.81 | 711.90 | 686.82 | 602.70 | 610.84 |
| EBITDA | 234.12 | 237.31 | 219.54 | 193.90 | 181.29 |
| Net Profit | 160.08 | 162.66 | 150.26 | 130.03 | 121.54 |
| EPS | 13.04 | 13.23 | 12.25 | 10.60 | 9.91 |
Alivus Life Sciences Ltd Technical Analysis
| Indicator | Value |
|---|---|
| RSI | 62.52 |
| MACD | 50.46 |
| 20-Day SMA | 1,331.12 |
Alivus Life Sciences Ltd Corporate Actions
| Corporate Action | Ex Date | Record Date |
|---|---|---|
| No forthcoming board meetings available. | ||
Alivus Life Sciences Ltd Peer Comparison
| Company | Price | M.Cap (Cr) | P/E (TTM) | ROE (TTM) |
|---|---|---|---|---|
| Sun Pharmaceutical Industries LtdSUNPHARMA | ₹1,913.30+0.73% | ₹4,19,727.66 | 38.32 | 13.74% |
| Divis Laboratories LtdDIVISLAB | ₹9,060.00+0.39% | ₹1,67,235.91 | 67.46 | 15.32% |
| Torrent Pharmaceuticals LtdTORNTPHARM | ₹4,999.00+2.23% | ₹1,46,951.32 | 64.68 | 25.49% |
Disclaimer
The information provided on this page is for informational purposes only and should not be construed as investment advice, recommendation, or solicitation to buy or sell any securities or financial pr...
Frequently Asked Questions
- The share price of Alivus Life Sciences Ltd today is ₹1,357.70 on NSE and ₹1,357.70 on BSE.
- The 52-week high of Alivus Life Sciences Ltd is ₹1,415.90, while the 52-week low is ₹830.00.
- The current market capitalisation of Alivus Life Sciences Ltd is approximately ₹16,669 crore.
- The P/E (Price-to-Earnings) ratio of Alivus Life Sciences Ltd is 27.64. The ratio may vary with changes in the share price and earnings.
- The P/B (Price-to-Book) ratio of Alivus Life Sciences Ltd is 5.00. It compares the company’s market value with its book value and can provide an indication of how the market values the company relative to its net assets.
- To invest in Alivus Life Sciences Ltd shares,
• Open a Demat and trading account with a registered broker
• Add funds to your account
• Search for Alivus Life Sciences Ltd on the trading platform
• Place a buy order
• Track your investments - Over the past 3 years, Alivus Life Sciences Ltd has delivered a return of approximately 119.76%. This return is based on the change in the share price over the specified period and may differ depending on the measurement date. Past performance does not guarantee future returns.
- The shareholding pattern of Alivus Life Sciences Ltd comprises different categories of shareholders. As of Jun 2026, the shareholding is approximately 74.87% promoters, -0.11% FIIs, 7.18% DIIs, and 10.05% public shareholders.
Download TradeMobi App
- Real-Time Market Data
- Advanced Trading Tools
- Expert-Backed Research
